Evidence map›Paper›PMID 42560045›Full record

ReviewMicrobiology and molecular biology reviews : MMBR2026

Translation factors that keep the ribosome Pro-active.

Heather A Feaga

Abstract readReview
In one paragraph

Review in Microbiology and molecular biology reviews : MMBR, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Collided ribosomes are rescued by the endonuclease Rae1 andbioRxiv : the preprint server for biology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Heather A FeagaDepartment of Microbiology, Cornell University, Ithaca, New York, USA.ORCID 0009-0007-3190-5135

Funding

Ribosome Quality Control Mechanisms in Gram-Positive BacteriaR35GM147049 · NIGMS · CORNELL UNIVERSITY · PI Heather Feaga · 2022 to 2026
$1.9M
NIGMS NIH HHS R35 GM147049NIGMS NIH HHS R35GM147049
6 · The paper itself

Abstract

SUMMARYRibosomes produce the staggering array of proteins that perform the structural and enzymatic feats of the cell. Therefore, most of the cell's energy goes toward producing ribosomes and the work performed by them. The work of the ribosome is relatively simple-decode mRNA codons and catalyze the formation of peptide bonds. By marching iteratively along the length of an open reading frame, a complete peptide is produced. Ribosomes catalyze the formation of peptide bonds at a rate of approximately 15 amino acids per second. However, bonds between amino acids do not form with equal efficiency, and ribosomes can become stalled at difficult-to-translate sequences. Proline is unique among the amino acids in that its side chain is covalently bonded to the peptide backbone to form a rigid ring. The rigidity of proline, and especially tracts of proline, makes it a difficult substrate for peptide bond formation, but it is also an essential motif in many protein structures. Elongation factor P (EF-P) is the star player for facilitating translation of polyproline tracts. However, recently identified factors play an important supporting role, and loss of these factors incurs a severe fitness defect in the absence of EF-P. These factors include an EF-P paralog, EfpL, as well as the ABCF ATPase YfmR/Uup and YebC2. The abundance and partial redundancy of factors that prevent ribosome stalling at polyprolines highlights the structural importance of polyproline tracts and the need to facilitate their translation. Here, we review recently identified translation factors that prevent ribosome stalling at polyprolines in bacteria.

Indexed as

Peptide Elongation FactorsProtein BiosynthesisRibosomesPeptidesProlinefactor EF-PPeptide Elongation FactorsPeptidespolyprolineProlinebacteriaribosometranslation

Identifiers

PMID42560045
PMCPMC13602936

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.